A pilot study of alpha-interferon and plicamycin for accelerated phase of chronic myeloid leukemia

Leukemia Research

Volumn 21, Issue 5, 1997, Pages 375-380

  Dutcher, Janice P ^a   Coletti, Deborah ^a   Paietta, Elisabeth ^a   Wiernik, Peter H ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Accelerated phase CML; Chronic myeloid leukemia (CML); Interferon; Leukemia; Plicamycin; Therapy CML

Indexed keywords

ALPHA INTERFERON; BUSULFAN; HYDROXYUREA; MITHRAMYCIN;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOGENETICS; DRUG SENSITIVITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; BIOPSY; BONE MARROW; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYDROXYUREA; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INTERFERON-ALPHA; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; PILOT PROJECTS; PLICAMYCIN; SURVIVAL RATE;

EID: 0030851551     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(96)00108-7     Document Type: Article

References (20)

1. Koeffler H. P. & Golde D. W. (1991) Chronic myelogenous leukemia: New concepts. N. Engl. J. Med. 304, 1269.
2. 1 chromosome. Blood 56, 356.
3. Hehlmann R., Heimpel H., Hasford J., Kolb H. J., Pralle H., Hossfeld D. K., Queiber W., Loffler H., Heinze B., Georgii A., Wussow P. V., Bartram C., Griebhammer M., Bergmann L., Essers U., Falge C., Hochhaus A., Queiber U., Sick C., Meyer P., Schmitz N., Verpoort K., Eimermacher H., Walther F., Westerhausen M., Kleeberg U. R., Heilein A., Kabisch A., Barz C., Zimmermann R., Meuret G., Tichelli A., Berdel W. E., Kanz L., Anger B., Tigges F. J., Schmid L., Brockhaus W., Zankovich R., Schlafer U., Weibenfels I., Mainzer K., Tobler A., Perker M., Hohnloser J., Messener D., Thiele J., Buhr T., Ansari H. & the German CML Study Group. (1993) Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: Prolongation of survival by hydroxyurea. Blood 82, 398.
4. Oladipupo-Williams C. K., Svet-Moldavskaya I., Vilcek J., Ohnuma T. & Holland J. F. (1981) Inhibitory effects of human leukocyte and fibroblast interferons on normal and chronic myelogenous leukemic granulocytic progenitor cells. Oncology 38, 356.
5. Peschel C., Aman M. J., Rudolf G., Aulitzky W. E. & Huber C. (1993) Regulation of the cytokine network by interferon: A potential mechanism of interferon in chronic myelogenous leukemia. Sem. Hematol. 30, (suppl 3), 28.
6. Talpaz M., Kantarjian H., Kurzrock R., Trujillo J. M. & Gutterman J. U. (1991) Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Ann. Intern. Med. 114, 532.
7. The Italian Cooperative Study Group on Chronic Myeloid Leukemia (1994) Interferon Alfa-2A as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N. Engl. J. Med. 330, 820.
8. Alimena G., Morra E., Lazzarino M., Liberati A. M., Montefusco E., Inverardi D., Bernasconi P., Mancini M., Donti E., Grignani F., Bernasconi C., Dianzani F. & Mandelli F. (1988) Interferon alpha-2b as therapy for Ph′-positive chronic myelogenous leukemia: A study of 82 patients treated with intermittent or daily administration. Blood 72, 642.
9. Yarbro J. W., Kennedy B. J. & Barnum C. P. (1968) Mithramycin inhibition of ribonucleic acid synthesis. Cancer Res. 24, 36.
10. Koller C. A., Campbell V. W., Polansky D. A., Mulhern A. & Miller D. M. (1985) In vivo differentiation of blast phase chronic granulocytic leukemia. Expression of c-myc and c-abl protooncogenes. J. Clin. Invest. 76, 365.
11. Koller C. A. & Miller D. M. (1986) Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea. N. Engl. J. Med. 315, 1433.
12. Arlin Z. A., Silver R. T. & Bennett J. M. (1990) Blast phase of chronic myeloid leukemia (blCML): A proposal for standardization of diagnostic and response criteria. Leukemia 4, 755.
13. Dutcher J. P., Eudey L., Wiernik P. H., Paietta E., Bennett J. M., Arlin Z., Kellermeyer R., Rowe J., O'Connell M., Oken M. & Cassileth P. A. (1992) Phase II study of mitoxatrone and 5-azacytidine for accelerated and blast crisis of chronic myelogenous leukemia: A study of the Eastern Cooperative Oncology Group. Leukemia 6, 770.
14. Schiffer C. A., DeBellis R., Kasdorf H. & Wiernik P. H. (1982) Treatment of the blast crisis of chronic myelogenous leukemia with 5-azacytidine and VP-16-213. Cancer Treat. Rep. 166, 267.
15. Kantarjian H. M., Walters R. S., Keating M. J., Talpaz M., Andersson B., Beran M., McCredie K. B. & Freireich E. J. (1988) Treatment of the blastic phase of chronic myelogenous leukemia with mitoxantrone and high dose cytosine arabinoside. Cancer 62, 672.
16. Kantarjian H. M., Talpaz M., Kontoyiannis D., Gutterman J., Keating M. J., Estey E. H., O'Brien S., Rios M. B., Beran M. & Deisseroth A. (1992) Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine and granulocyte-macrophage colony-stimulating factor. J. Clin. Oncol. 10, 398.
17. Sokal J. E., Gomez G. A., Baccarani M., Tura S., Clarkson B. D., Cervantes F., Rozman C., Carbonell F., Anger B., Heimpel H., Nissen N. I. & Robertson J. E. (1988) Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia. Blood 72, 294.
18. Sokal J. E., Cox E. B., Baccarani M., Tura S., Gomez G. A., Robertson J. E., Tso C. Y., Braun T. J., Clarkson B. D., Cervantes F., Rozman C. & the Italian Cooperative CML Study Group (1984) Prognostic discrimination in good risk chronic granulocytic leukemia. Blood 63, 789.
19. Clift R. A., Buckner C. D., Thomas E. D., Bryant E., Anasetti C., Bensinger W. I., Bowden R., Deeg H. J., Doney K. C., Fisher L. D., Hansen J. A., Martin P., McDonald G. B., Sanders J. E., Schoch G., Singer J., Storb R., Sullivan K. M., Witherspoon R. P. & Appelbaum F. R. (1994) Marrow transplantation for patients in accelerated phase of chronic myelogenous leukemia. Blood 84, 4368.
20. Jehn U., Potscher Ch. & Heinemann V. (1995) Successful treatment of accelerated and blastic phase of chronic myeloid leukemia with high-dose interferon alpha and hydroxyurea: A novel approach. Leuk. Lymph. 19, 153.